CARB-ES-19 multicenter study of carbapenemase-producing klebsiella pneumonia e and escherichia coli from all spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3
| UDC.coleccion | Investigación | es_ES |
| UDC.departamento | Fisioterapia, Medicina e Ciencias Biomédicas | es_ES |
| UDC.grupoInv | Investigación en Microbiología (INIBIC) | es_ES |
| UDC.institutoCentro | INIBIC - Instituto de Investigacións Biomédicas de A Coruña | es_ES |
| UDC.journalTitle | Frontiers in Microbiology | es_ES |
| UDC.startPage | 918362 | es_ES |
| UDC.volume | 13 | es_ES |
| dc.contributor.author | Cañada-García, Javier E. | |
| dc.contributor.author | Moure, Zaira | |
| dc.contributor.author | Sola-Campoy, Pedro Juan | |
| dc.contributor.author | Delgado-Valverde, Mercedes | |
| dc.contributor.author | Cano, María E. | |
| dc.contributor.author | Gijón, Desiree | |
| dc.contributor.author | González, Mónica | |
| dc.contributor.author | Gracia-Ahufinger, Irene | |
| dc.contributor.author | Larrosa, Nieves | |
| dc.contributor.author | Mulet, Xavier | |
| dc.contributor.author | Pitart, Cristina | |
| dc.contributor.author | Rivera, Alba | |
| dc.contributor.author | Bou, Germán | |
| dc.contributor.author | Calvo-Montes, Jorge | |
| dc.contributor.author | Cantón, Rafael | |
| dc.contributor.author | González-López, Juan José | |
| dc.contributor.author | Martínez-Martínez, Luis | |
| dc.contributor.author | Navarro, Ferrán | |
| dc.contributor.author | Oliver, Antonio | |
| dc.contributor.author | Palacios-Baena, Zaira R. | |
| dc.contributor.author | Pascual, Álvaro | |
| dc.contributor.author | Ruiz Carrascoso, Guillermo | |
| dc.contributor.author | Vila, Jordi | |
| dc.contributor.author | Aracil, Belén | |
| dc.contributor.author | Pérez-Vázquez, María | |
| dc.contributor.author | Oteo, Jesús | |
| dc.date.accessioned | 2025-02-12T07:39:10Z | |
| dc.date.available | 2025-02-12T07:39:10Z | |
| dc.date.issued | 2022-06-30 | |
| dc.description.abstract | [Abstract] Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3. | es_ES |
| dc.description.sponsorship | This research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014–2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work. | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; PI18CIII/00030 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; PI21CIII/00039 | es_ES |
| dc.description.sponsorship | España. Ministerio de Economía y Competitividad; RD16CIII/0004/0002 | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0001/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0003/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0004/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0006/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0007/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0008/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0010/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | info:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0011/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00095 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00012 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00049 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00054 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00055 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00068 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00081 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00084 | es_ES |
| dc.description.sponsorship | Instituto de Salud Carlos III; CB21/13/00099 | es_ES |
| dc.identifier.citation | Cañada-García JE, Moure Z, Sola-Campoy PJ, Delgado-Valverde M, Cano ME, Gijón D, González M, Gracia-Ahufinger I, Larrosa N, Mulet X, Pitart C, Rivera A, Bou G, Calvo J, Cantón R, González-López JJ, Martínez-Martínez L, Navarro F, Oliver A, Palacios-Baena ZR, Pascual Á, Ruiz-Carrascoso G, Vila J, Aracil B, Pérez-Vázquez M, Oteo-Iglesias J; GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group. CARB-ES-19 multicenter study of carbapenemase-producing klebsiella pneumonia e and escherichia coli from all spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3. Front Microbiol. 2022 Jun 30;13:918362. | es_ES |
| dc.identifier.doi | 10.3389/fmicb.2022.918362 | |
| dc.identifier.issn | 1664-302X | |
| dc.identifier.uri | http://hdl.handle.net/2183/41161 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Frontiers Media | es_ES |
| dc.relation.uri | https://doi.org/10.3389/fmicb.2022.918362 | es_ES |
| dc.rights | Creative Commons Attribution 4.0 International License (CC-BY 4.0) | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.subject | CARB-ES-19 study | es_ES |
| dc.subject | Klebsiella pneumoniae | es_ES |
| dc.subject | Carbapenemases | es_ES |
| dc.subject | High-risk clones | es_ES |
| dc.subject | Whole genome sequencing | es_ES |
| dc.title | CARB-ES-19 multicenter study of carbapenemase-producing klebsiella pneumonia e and escherichia coli from all spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3 | es_ES |
| dc.type | journal article | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 909e08d1-6ed1-4b99-9e9e-c64eb72e7dea | |
| relation.isAuthorOfPublication.latestForDiscovery | 909e08d1-6ed1-4b99-9e9e-c64eb72e7dea |
Files
Original bundle
1 - 5 of 6
Loading...
- Name:
- Canada_CARB_ES-19_2022.pdf
- Size:
- 3.64 MB
- Format:
- Adobe Portable Document Format
- Description:
Loading...
- Name:
- Canada_CARB_ES-19_2022_Suppl_1.pdf
- Size:
- 243.79 KB
- Format:
- Adobe Portable Document Format
- Description:
- Table 1
Loading...
- Name:
- Canada_CARB_ES-19_2022_Suppl_2.pdf
- Size:
- 634.12 KB
- Format:
- Adobe Portable Document Format
- Description:
- Table 2
Loading...
- Name:
- Canada_CARB_ES-19_2022_Suppl_3.pdf
- Size:
- 252.71 KB
- Format:
- Adobe Portable Document Format
- Description:
- Table 3
Loading...
- Name:
- Canada_CARB_ES-19_2022_Suppl_4.pdf
- Size:
- 185.17 KB
- Format:
- Adobe Portable Document Format
- Description:
- Table 4

